SGYP News and Press, Synergy Pharmaceuticals Inc.

NEW YORK , March 6, 2019 /PRNewswire/ -- Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) (the "Company" or "Synergy"), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today confirmed that the previously announced sale of c...

LAVAL, Quebec , March 6, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that the Company has completed the acquisition of certain assets of Synergy Pharmaceuticals Inc. (NASD: SGYP) ("Synergy") for a cash purchase ...

It was an extremely sad day for Synergy Pharmaceuticals ( SGYP ) shareholders last week as a scheduled auction for February 26 didn't go through as no other bidders submitted offers to buy the company assets or proposed a plan of reorganization. Synergy whose market cap at one time surpassed...

CORAL GABLES, FL / ACCESSWIRE / March 4, 2019 / The healthcare stock market has managed to consistently garner significant amounts of attention over the course of the last few months, as more healthcare companies have focused their efforts on developing innovative care options for their pa...

Synergy Pharmaceuticals (NASDAQ: SGYP ) has gotten court approval for the sale of certain of its assets to Bausch Health Cos. (NYSE: BHC ). More news on: Synergy Pharmaceuticals, Inc., Bausch Health Companies Inc., Healthcare stocks news, Merger & acquisition news, Stocks on the move...

NEW YORK , March 1, 2019 /PRNewswire/ -- Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) (the "Company" or "Synergy"), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today confirmed that the previously announced agre...

Bausch Health Companies (NYSE: BHC ) has agreed to acquire certain assets of bankrupt Synergy Pharmaceuticals (NASDAQ: SGYP ) for ~$195M in cash plus the assumption of certain liabilities. More news on: Bausch Health Companies Inc., Synergy Pharmaceuticals, Inc., Healthcare stocks news, ...

Bausch Health and Synergy to Seek Bankruptcy Court Approval of Sale on March 1, 2019 LAVAL, Quebec , Feb. 26, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that the Company was selected as the successful bid...

NEW YORK , Feb. 26, 2019 /PRNewswire/ -- Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) (the "Company" or "Synergy"), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today confirmed that the previously announced agre...

Amarin ( AMRN ) has been a darling of biotech investors with one of the highest bullish sentiments that I have seen on a stock. I will not go into the details of the background of this stock since I assume that you are familiar with it. Amarin's sole product Vascepa has a proprietary formulati...